SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Tower’s surge continues as valuation crosses $20 billion mark

Learning to manage the cloud without losing control

Cash-strapped AI chip startup Hailo sees valuation halved to under $500 million ahead of urgent IPO

Israeli drone factory hit by Iranian missile

Buzz

Most popular

Daily

Weekly

1

Israel gas cutoff exposes deep energy divide between Jordan and Egypt

2

Israeli drone factory hit by Iranian missile

3

“Today is your last day”: Oracle’s mass layoffs unfold without warning

4

Israel’s tallest tower planned: 111 floors in Ramat Gan “Vertical City”

5

"Cyera is already the Wiz of data security. We want to be the Palo Alto Networks of data security"

Blood Cancer

4 stories about Blood Cancer

אחות אחיות רפואה סיעוד

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer

The investment is part of a licensing option agreement signed between the two companies

פרופסור זליג אשחר

Scientist’s Ex-Wife Joins Legal Melee Over Kite Pharma Windfall

16.01.18|Zohar Shahar Levy

Zelig Eshhar, the patent holder for Kite Pharma’s anti-cancer technology, is currently being sued by a former student for infringement of patent rights

המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer

The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor

Kite Pharma’s Cancer Drug Gets Regulatory Nod

19.10.17|Lilach Baumer

The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000